mequinol has been researched along with Lentigo in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henry, F; Piérard, GE; Piérard-Franchimont, C; Quatresooz, P; Vroome, V | 1 |
| Hussar, DA | 1 |
| Bergfelt, L; Camacho, F; Ortonne, JP; Roseeuw, D; Wainwright, N; Westerhof, W | 1 |
| Jarratt, M | 1 |
| Draelos, ZD | 1 |
| Altman, DJ; Colby, SI; Fleischer, AB; Schwartzel, EH | 1 |
5 trial(s) available for mequinol and Lentigo
| Article | Year |
|---|---|
Analytic quantification of the bleaching effect of a 4-hydroxyanisole-tretinoin combination on actinic lentigines.
Topics: Absorptiometry, Photon; Administration, Cutaneous; Aged; Anisoles; Antioxidants; Dermoscopy; Drug Therapy, Combination; Female; Follow-Up Studies; Hand Dermatoses; Humans; Keratolytic Agents; Lentigo; Middle Aged; Skin Aging; Spectrophotometry; Sunlight; Tretinoin; Ultraviolet Rays; Video Recording | 2008 |
Safety and efficacy of combined use of 4-hydroxyanisole (mequinol) 2%/tretinoin 0.01% solution and sunscreen in solar lentigines.
Topics: Administration, Cutaneous; Adult; Anisoles; Dermatologic Agents; Female; Humans; Hypopigmentation; Keratolytic Agents; Lentigo; Male; Severity of Illness Index; Sunscreening Agents; Time Factors; Treatment Outcome; Tretinoin | 2004 |
Mequinol 2%/tretinoin 0.01% solution: an effective and safe alternative to hydroquinone 3% in the treatment of solar lentigines.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Anisoles; Double-Blind Method; Drug Therapy, Combination; Face; Female; Forearm; Humans; Hydroquinones; Keratolytic Agents; Lentigo; Male; Middle Aged; Treatment Outcome; Tretinoin | 2004 |
The combination of 2% 4-hydroxyanisole (mequinol) and 0.01% tretinoin effectively improves the appearance of solar lentigines in ethnic groups.
Topics: Adult; Aged; Aged, 80 and over; Anisoles; Antioxidants; Drug Combinations; Ethnicity; Face; Female; Humans; Keratolytic Agents; Lentigo; Male; Middle Aged; Tretinoin | 2006 |
The combination of 2% 4-hydroxyanisole (Mequinol) and 0.01% tretinoin is effective in improving the appearance of solar lentigines and related hyperpigmented lesions in two double-blind multicenter clinical studies.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Anisoles; Antioxidants; Arm; Double-Blind Method; Drug Therapy, Combination; Facial Dermatoses; Female; Hand Dermatoses; Humans; Hyperpigmentation; Keratolytic Agents; Lentigo; Male; Middle Aged; Severity of Illness Index; Treatment Outcome; Tretinoin | 2000 |
1 other study(ies) available for mequinol and Lentigo
| Article | Year |
|---|---|
New drugs 04, part 1.
Topics: Adalimumab; Alefacept; alpha-Galactosidase; Anisoles; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antioxidants; Antiprotozoal Agents; Antirheumatic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Drug Approval; Drug Therapy; Fabry Disease; Gefitinib; Humans; Iduronidase; Indoles; Isoenzymes; Lentigo; Lung Neoplasms; Migraine Disorders; Mucopolysaccharidosis I; Nitro Compounds; Patient Education as Topic; Propylamines; Psoriasis; Pyrrolidines; Quinazolines; Recombinant Fusion Proteins; Serotonin Receptor Agonists; Thiazoles; Tryptamines | 2004 |